NIKKO ASSET MANAGEMENT AMERICAS, INC. – CRISPR Therapeutics AG Transaction History
NIKKO ASSET MANAGEMENT AMERICAS, INC. portfolio value:
$277.07M
portfolio value
NIKKO ASSET MANAGEMENT AMERICAS, INC. quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.01% | -321.36K shares | 1.02M | $65.35 | 4.26M |
| Q2 2022 | share | Decrease | -0.77% | -35.64K shares | -14.99M | $60.77 | 4.58M |
| Q1 2022 | share | Increase | +6.95% | 300.27K shares | -39.48M | $62.77 | 4.61M |
| Q4 2021 | share | Increase | +31.31% | 1.02M shares | -37.9M | $78.85 | 4.31M |
| Q3 2021 | share | Decrease | -2.78% | -93.94K shares | -179.69M | $111.93 | 3.28M |
| Q2 2021 | share | Decrease | -7.55% | -276.40K shares | 102.16M | $161.89 | 3.38M |
| Q1 2021 | share | Decrease | -4.61% | -176.95K shares | -141.50M | $121.85 | 3.65M |
| Q4 2020 | share | Increase | +3.76% | 139.15K shares | 278.70M | $153.11 | 3.83M |
| Q3 2020 | share | Decrease | -0.39% | -14.30K shares | 39.63M | $83.64 | 3.69M |
| Q2 2020 | share | Decrease | -1.45% | -54.57K shares | 109.37M | $73.49 | 3.71M |
| Q1 2020 | share | Increase | +23.51% | 716.98K shares | -25.99M | $42.41 | 3.76M |
| Q4 2019 | share | Increase | +9.80% | 272.13K shares | 71.88M | $60.91 | 3.04M |
| Q3 2019 | share | Increase | +48.41% | 906.00K shares | 25.70M | $40.99 | 2.77M |
| Q2 2019 | share | Increase | +324.31% | 1.43M shares | 72.38M | $47.1 | 1.87M |
| Q1 2019 | share | Increase | +47632.03% | 440.12K shares | 15.72M | $35.72 | 441.04K |
| Q4 2018 | share | Decrease | -17.79% | -200 shares | -24K | $28.57 | 924 |
| Q3 2018 | share | Increase | 0.00% | 1.12K shares | 50K | $44.35 | 1.12K |